Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and <i>KIT</i> and/or <i>FLT3</i>- ITD mutations: results of the SAL MIDOKIT trial

• Leo Ruhnke,
• Christoph Röllig,
• Sylvia Herold,
• Tim Sauer,
• Christian H. Brandts,
• Björn Steffen,
• Kerstin Schäfer-Eckart,
• Stefan W. Krause,
• Mathias Hänel,
• Albrecht Reichle,
• Sebastian Scholl,
• Andreas Neubauer,
• Jan-Henrik Mikesch,
• Johannes Schetelig,
• Friedrich Stölzel,
• Michael Kramer,
• Annett Haake,
• Julia Frimmel,
• Alwin Krämer,
• Richard Schlenk,
• Uwe Platzbecker,
• Hubert Serve,
• Claudia D. Baldus,
• Carsten Müller-Tidow,
• Daniela Aust,
• Martin Bornhäuser,
• Gerhard Ehninger,
• Christian Thiede

Affiliations

Leo Ruhnke

Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden

Christoph Röllig

Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden

Sylvia Herold

Institute of Pathology, University Hospital Dresden, Dresden

Tim Sauer

Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg

Christian H. Brandts

Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt

Björn Steffen

Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt

Kerstin Schäfer-Eckart

Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg

Stefan W. Krause

Department of Internal Medicine V, University Hospital Erlangen, Erlangen

Mathias Hänel

Department of Internal Medicine III, Chemnitz Hospital, Chemnitz

Albrecht Reichle

Department of Internal Medicine III, Hematology and Internal Oncology, University Hospital Regensburg, Regensburg

Sebastian Scholl

Department of Internal Medicine II, Hematology and Internal Oncology, University Hospital Jena, Jena

Andreas Neubauer

Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg, Marburg

Jan-Henrik Mikesch

Department of Internal Medicine A, University Hospital Münster, Münster

Johannes Schetelig

Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; DKMS Clinical Trials Unit, Dresden

Friedrich Stölzel

Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden

Michael Kramer

Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden

Annett Haake

Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden

Julia Frimmel

Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden

Alwin Krämer

Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg

Richard Schlenk

Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg

Uwe Platzbecker

Department of Internal Medicine I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig

Hubert Serve

Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt

Claudia D. Baldus

Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel

Carsten Müller-Tidow

Department of Internal Medicine V, University of Heidelberg, Heidelberg

Daniela Aust

Institute of Pathology, University Hospital Dresden, Dresden

Martin Bornhäuser

Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT) Dresden, Dresden

Gerhard Ehninger

Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden

Christian Thiede

Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; Agendix GmbH, Dresden